Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Reboocon Intuy Knee

Research Leaders

5 sponsors active, led by Hanger Clinic: Prosthetics & Orthotics

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (3)

Trial Status

Recruiting2
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Research Network

Common Treatments

  • Reboocon Intuy Knee1
  • Ottobock Kenevo1
  • Ossur Power Knee1
  • Power Knee1
  • Ottobock Cleg 4 Microprocessor Knee1

Active Sponsors

  • Hanger Clinic: Prosthetics & Orthotics2
  • Liberating Technologies, Inc.2
  • University of Washington1
  • U.S. Army Medical Research Acquisition Activity1
  • Hanger Institute for Clinical Research and Education, LLC1

Top Investigators

Related Conditions

  • Lower Limb Amputation Above Knee Injury3
  • Limb Absence Congenital Lower3
  • Amputation3
  • Prosthesis User3
  • Amputation Traumatic Leg Lower2

Activity Timeline